Seeing Is Believing
Currently out of the existing stock ratings of Daniel Markowitz, 37 are a BUY (84.09%), 7 are a HOLD (15.91%).
Analyst Daniel Markowitz, currently employed at EVERCORE, carries an average stock price target met ratio of 58.54% that have a potential upside of 18.76% achieved within 90 days.
Daniel Markowitz’s has documented 88 price targets and ratings displayed on 9 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on NTRA, Natera at 07-Aug-2026.
Analyst best performing recommendations are on NTRA (NATERA).
The best stock recommendation documented was for TECH (BIO-TECHNE CORP) at 5/7/2026. The price target of $50 was fulfilled within 1 day with a profit of $0.91 (1.79%) receiving and performance score of 17.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Sep-2025
$135
$40.08 (42.23%)
$130
4 months 14 days ago
(08-May-2026)
1/4 (25%)
$39.3 (41.07%)
25
Buy Since 23-Jan-2025
$120
$25.08 (26.42%)
$115
4 months 14 days ago
(08-May-2026)
5/8 (62.5%)
$24.3 (25.39%)
117
Buy Since 26-Feb-2024
$130
$35.08 (36.96%)
$120
6 months 29 days ago
(24-Feb-2026)
12/14 (85.71%)
$34.6 (36.27%)
338
Buy Since 16-Apr-2019
$145
$50.08 (52.76%)
$140
7 months 2 days ago
(20-Feb-2026)
18/21 (85.71%)
$41.9 (40.64%)
316
Buy Since 11-Jan-2021
$130
$35.08 (36.96%)
$120
7 months 2 days ago
(20-Feb-2026)
3/5 (60%)
$26.9 (26.09%)
75
Which stock is Daniel Markowitz most bullish on?
Which stock is Daniel Markowitz most reserved on?
What Year was the first public recommendation made by Daniel Markowitz?